Toggle Main Menu Toggle Search

Open Access padlockePrints

Attitudes of patients and family members towards implantable psychiatric medication

Lookup NU author(s): Professor Allan Young


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Introduction: Medication is a necessary part of treatment for severe psychiatric illnesses such as schizophrenia and nonadherence to prescribed medication is one of the most important public health issues in psychiatry today. The devastating consequences of nonadherence have motivated the development of novel therapeutic strategies, including a new long-term implantable medication delivery system. Methods: The current study assesses attitudes towards implantable medication in psychiatric patients and their family members. Patients included in the study had diagnoses of Schizophrenia, Schizoaffective Disorder, Mood or Anxiety related disorders. Results: 49.62% of patients and 74.47% of family members endorse support for implantable medication. Conclusions: This study demonstrates that implants may be an acceptable alternative to oral and injectable medication for a subset of psychiatric patients and their families. © 2008 Elsevier B.V. All rights reserved.

Publication metadata

Author(s): Dankert ME, Brensinger CM, Metzger KL, Li C, Koleva SG, Mesen A, Laprade B, Wiguna T, Han C, Farooq S, Severus WE, Gayares JG, Langosch JM, Lallart X, Tateno M, Mihai A, Nair SRN, Belmaker R, Rybakowski J, Owe-Larsson B, Kane JM, Johnstone EC, MacIntyre DJ, Malhotra S, Gonzalez-Pinto A, Mosquera F, Babb SM, Habib pour E, Fatemi SS, Swanson C, Adler C, Young A, Hoeft F, Sivakumar K, Radoeva PD, Lallart EA, Bilker WB, Siegel SJ

Publication type: Article

Publication status: Published

Journal: Schizophrenia Research

Year: 2008

Volume: 105

Issue: 1

Pages: 279-286

ISSN (print): 0920-9964

ISSN (electronic): 1573-2509

Publisher: Elsevier BV


DOI: 10.1016/j.schres.2008.05.008


Altmetrics provided by Altmetric


Funder referenceFunder name
RCG 01-314The Stanley Medical Research Institute